Cita APA

de Almeida, M. H., Fogliatto, L., & Couto, D. (2014). Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia. Sociedade Brasileira de Hematologia e Hemoterapia.

Chicago Style Citation

de Almeida, Maria Helena, Laura Fogliatto, i Dulce Couto. Importance of Adherence to BCR-ABL Tyrosine-kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia. Sociedade Brasileira de Hematologia e Hemoterapia, 2014.

Cita MLA

de Almeida, Maria Helena, Laura Fogliatto, i Dulce Couto. Importance of Adherence to BCR-ABL Tyrosine-kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia. Sociedade Brasileira de Hematologia e Hemoterapia, 2014.